CA2717012A1 - Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases - Google Patents

Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases Download PDF

Info

Publication number
CA2717012A1
CA2717012A1 CA2717012A CA2717012A CA2717012A1 CA 2717012 A1 CA2717012 A1 CA 2717012A1 CA 2717012 A CA2717012 A CA 2717012A CA 2717012 A CA2717012 A CA 2717012A CA 2717012 A1 CA2717012 A1 CA 2717012A1
Authority
CA
Canada
Prior art keywords
glucuronide
beta
quercetin
heart
kaempferol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2717012A
Other languages
English (en)
French (fr)
Inventor
Anke Esperester
Stephan Nees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of CA2717012A1 publication Critical patent/CA2717012A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA2717012A 2008-03-06 2009-03-03 Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases Abandoned CA2717012A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008012909.7 2008-03-06
DE102008012909A DE102008012909A1 (de) 2008-03-06 2008-03-06 Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen
PCT/EP2009/052502 WO2009109573A1 (de) 2008-03-06 2009-03-03 Verwendung von flavonoidverbindungen für die propyhylaxe und therapie ischämischer oder entzündlicher herz- und kreislauferkrankungen

Publications (1)

Publication Number Publication Date
CA2717012A1 true CA2717012A1 (en) 2009-09-11

Family

ID=40600026

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2717012A Abandoned CA2717012A1 (en) 2008-03-06 2009-03-03 Use of flavonoide compounds for the propyhylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases

Country Status (6)

Country Link
US (2) US20110053874A1 (enExample)
EP (1) EP2268277A1 (enExample)
JP (1) JP2011527984A (enExample)
CA (1) CA2717012A1 (enExample)
DE (1) DE102008012909A1 (enExample)
WO (1) WO2009109573A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2195000B1 (de) * 2007-08-31 2019-09-25 Sanofi-Aventis Deutschland GmbH Sprühfähige zusammensetzung enthaltend extrakt aus rotem weinlaub
DE102008012908A1 (de) * 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten
AU2013330222B2 (en) 2012-10-11 2016-05-12 Armaron Bio Pty Ltd Novel flavonoid compounds and uses thereof
CN113398114B (zh) * 2021-05-28 2022-11-01 浙江大学智能创新药物研究院 3,7,8,4′-四羟基黄酮在制备抗心血管疾病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1190200C (zh) * 1998-10-29 2005-02-23 默克专利股份有限公司 包括生物黄酮醇类的混合物的组合物
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
ATE322904T1 (de) * 2000-05-25 2006-04-15 Boehringer Ingelheim Int Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält
CN1197567C (zh) * 2002-10-21 2005-04-20 中国人民解放军第二军医大学 山奈酚衍生物用于制备防治脑血管疾病药物的用途
JP4989071B2 (ja) 2002-12-31 2012-08-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 赤ブドウ葉抽出物を含むフィルムコート錠

Also Published As

Publication number Publication date
WO2009109573A1 (de) 2009-09-11
EP2268277A1 (de) 2011-01-05
DE102008012909A1 (de) 2009-09-10
US20130109641A1 (en) 2013-05-02
US20110053874A1 (en) 2011-03-03
JP2011527984A (ja) 2011-11-10

Similar Documents

Publication Publication Date Title
Grassi et al. Flavonoids, vascular function and cardiovascular protection
Dludla et al. Hyperglycemia-induced oxidative stress and heart disease-cardioprotective effects of rooibos flavonoids and phenylpyruvic acid-2-O-β-D-glucoside
Nijveldt et al. Flavonoids: a review of probable mechanisms of action and potential applications
Lockyer et al. Olive leaf phenolics and cardiovascular risk reduction: physiological effects and mechanisms of action
JP2001526658A (ja) 虚血の治療および／または予防を行う際の医薬組成物の使用
Bernatoniene et al. The effect of crataegus fruit extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart
NO339322B1 (no) Formuleringer inneholdende cynara scolymus og phaseolus vulgaris ekstrakter som er nyttige i behandlingen av fedme
JP5898825B2 (ja) 腸内有害菌低減剤、それを含む食品または医薬品
Dall’Asta et al. Protection of pancreatic β-cell function by dietary polyphenols
US20130109641A1 (en) Use of flavonoide compounds for the prophylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases
US10213450B2 (en) Combination of biologically active substances for treatment of hyperglycaemic disorders
ES2342018T3 (es) Metodo de tratamiento de afecciones inflamatorias usando extractos de maracuya.
Taie et al. Chemical composition and biological activities of two Solanum tuberosum cultivars grown in Egypt
JP2008007452A (ja) 膵β細胞保護剤
WO2004096240A1 (en) Anthocyanins useful for the treatment of diabetes, cardiovascular disorders and to lower the risk of adverse effects of hormone replacement therapy
Jafari-Khataylou et al. Troxerutin attenuates inflammatory response in lipopolysaccharide-induced sepsis in mice
KR20140077483A (ko) 갯방풍 추출물을 포함하는 허혈성 뇌혈관 질환 예방 또는 개선용 조성물
JP2007520431A (ja) 血糖降下用組成物
KR20180106103A (ko) 우엉 추출물을 포함하는 항염증성 및 염증성 신경퇴행성 질환 예방 또는 치료용 조성물
Punz et al. Multivitamin administration before ischemia reducesischemia-reperfusion injury in rabbit skeletal muscle
JP2009137920A (ja) グリコーゲンホスホリラーゼ阻害剤
JP2014240431A (ja) 腸内有害菌低減剤、それを含む食品または医薬品
KR20200063772A (ko) 진세노사이드 Re를 포함하는 거저리 유충 추출물을 유효성분으로 포함하는 항염증용 조성물
JP2005306801A (ja) ハマナス類由来のα−アミラーゼ阻害剤、α−グルコシダーゼ阻害剤、グルコース吸収阻害剤およびその利用
JP2009196981A (ja) 血中アディポネクチン量増加剤

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140304